Tuesday, 4 February 2025 at 10.00 – 11.00am CET
In connection with the publication of Coloplast’s interim financial results for Q1 2024/25, to be released same day around 07.30am CET, Coloplast will host a conference call to present the financial results and answer questions from investors and financial analysts. A presentation will be available on Coloplast’s website approximately 1 hour before the conference call.
The webcast of the conference call will be available during and after the event.
Coloplast will be represented by:
Kristian Villumsen – President & CEO
Anders Lonning-Skovgaard – Executive Vice President, CFO
Aleksandra Dimovska – Vice President, Investor Relations
Simone Dyrby Helvind – Senior Manager, Investor Relations
Webcast
For participants who do not wish to actively participate in the Q&A session, please access the conference call as a webcast via the link below:
Access the webcast here
Dial-in details
To actively participate in the Q&A session, please sign up ahead of the conference call on the link below to receive an email with dial-in details.
Register for the conference call here
For more information, please contact:
Aleksandra Dimovska – Vice President, Investor Relations
Tel.: +45 4911 1800 / direct: +45 4911 2458. E-mail: [email protected]
Simone Dyrby Helvind – Senior Manager, Investor Relations
Tel.: +45 4911 1800 / direct: +45 4911 2981. E-mail: [email protected]
Julie Isabella Sommer Müggler – Coordinator & PA, Investor Relations
Tel.: +45 4911 1800 / direct: +45 4911 3161. E-mail: [email protected]
Coloplast will be available on individual phone lines after the conference call for further questions.
Attachment
Invitation for Coloplasts Q1 2024-25 conference call on 4 february 2025
